Evidence map›Paper›PMID 23519121›Full record

ArticleCell death & disease2013

Nox4-dependent ROS modulation by amino endoperoxides to induce apoptosis in cancer cells.

P Zhu, B M K Tong, R Wang, J P Chen, S Foo, H C Chong, X L Wang, G Y Ang, S Chiba, N S Tan

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Experimental and therapeutic medicine · 2021
    Article
  4. Article
  5. Nox4 regulates InsPThe EMBO journal · 2020
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Differential effect of artemisinin against cancer cell lines.Natural products and bioprospecting · 2014
    Article
  13. Article
  14. Review
  15. Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.IEEE/ACM transactions on computational biology and bioinformatics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

P ZhuSchool of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
B M K Tong
R Wang
J P Chen
S Foo
H C Chong
X L Wang
G Y Ang
S Chiba
N S Tan
Nanyang Technological University · SGAgency for Science, Technology and Research · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor metastasis is the main cause of death in cancer patients. Anoikis resistance is one critical malefactor of metastatic cancer cells to resist current clinical chemotherapeutic treatments. Although endoperoxide-containing compounds have long been suggested as anticancer drugs, few have been clinically employed due to their instability, complex synthesis procedure or low tumor cell selectivity. Herein, we describe a one-pot strategy to synthesize novel amino endoperoxides and their derivatives with good yields and stabilities. In vitro cell-based assays revealed that 4 out of the 14 amino endoperoxides selectively induce metastatic breast carcinoma cells but not normal breast cells to undergo apoptosis, in a dose-dependent manner. Mechanistic studies showed that the most potent amino endoperoxide, 4-Me, is selective for cancer cells expressing a high level of Nox4. The anticancer effects are further shown to be associated with reduced O2(-):H2O2 ratio and increased ·OH level in the cancerous cells. Animal study showed that 4-Me impairs orthotopic breast tumor growth as well as tumor cell metastasis to lymph nodes. Altogether, our study suggests that anticancer strategies that focus on redox-based apoptosis induction in tumors are clinically viable.

Indexed as

AnoikisAntineoplastic AgentsBreast NeoplasmsCarcinomaCell Line, TumorDose-Response Relationship, DrugFemaleGene Expression Regulation, NeoplasticHumansNADPH Oxidase 4NADPH OxidasesNeoplasm MetastasisOxidation-ReductionPeroxidesReactive Oxygen SpeciesSignal TransductionAntineoplastic AgentsNADPH Oxidase 4NADPH OxidasesNOX4 protein, humanPeroxidesReactive Oxygen Species

Identifiers

PMID23519121
PMCPMC3615744
OpenAlexW2145243913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.